Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes-Firm-with-FDA-domain-expertice-is-submitting-and-handling-510k-not-Biel
Name not shared or confirmed. may or may not be firm cited in PR.
...support from the law firm of Goodwin Proctor.....
Oops-neglected-submit-that-question
For-that-rational-to-hold-they-also-would-not-share-additional-channels-being-added
Understanding-is-TENS-and-PEMF-share-same-targeted-customer-base
Yep-If-u-r-looking-for-a-CPU-or-related-component
So, does Yahoo Finance:
http://finance.yahoo.com/q/co?s=AMD+Competitors
fair-enough-then-you-still-are-intersted-in-factors-that-impact-pps
In this example if the company shared number of units being sold into channels over given period of time. If this showed significant month over months gains, then would expect PPS to reflect positive news.
If company shared these details would not be resorting to alternative approach for gather insightful data, which is to compare sales against like products in identical channel.
Does-not-matter-competing-for-same-customers-money
All that matters to you as an investor is the customer is choosing alternative product when competing in same identical channel.
Are-you-investor-or-what-all-that-matters-is-units-sold
If you are investor, reasons are less important, what matters is customers are buying alternative product which infers less revenue for company you are invested in.
apple-to-apple-comparison-both-products-operaitng-within-same-sales-channel
Amazon-eBay-Walgreens-all-viable-sales-channels
Walgreens/Boots -> Market cap 92.16B
eBay ...........-> Market Cap: 33.49B
Amazon .........-> Market Cap: 310.60B
Just not feasible to know/report sell through numbers for Amazon & Walgreens.
Using a known/reputable channel that does provide sell through data.
Agreed though, not the best comparison, using what data is available to compare.
eBay Uk shows 35 items sold.
http://www.ebay.co.uk/sch/i.html?_from=R40&_nkw=actipatch&_in_kw=1&_ex_kw=&_sacat=0&LH_Sold=1&_udlo=&_udhi=&_samilow=&_samihi=&_sargn=-1%26saslc%3D1&_salic=3&_sop=12&_dmd=1&_ipg=50&LH_Complete=1
Tell-that-to-the-275-individuals-who-baught-alternative-product-88%-Market-share
275/(275+35) --> 88% Channel Market share for alternative product
Customers are always right.
Not-according-to-ebay-auction-results-customers-prefer-alternative-product
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=119342198
Facts-Actipatch-6+27-items-sold-vs-Icy-Hot-Tens-274-items-sold
Following a comparative search for:
Icy Hot Smart Relief Tens
Shows 274 listings "Sold"
--> http://www.ebay.com/sch/i.html?_nkw=Icy+Hot+Smart+Relief+Tens+&_in_kw=1&_ex_kw=&_sacat=0&LH_Sold=1&_udlo=&_udhi=&_samilow=&_samihi=&_sadis=15&_stpos=95120&_sargn=-1%26saslc%3D1&_salic=1&_sop=12&_dmd=1&_ipg=200&LH_Complete=1
Then, Actipatch
Shows 6+27 listings "Sold"
--> http://www.ebay.com/sch/i.html?_from=R40&_nkw=Actipatch&_in_kw=1&_ex_kw=&_sacat=0&LH_Sold=1&_udlo=&_udhi=&_samilow=&_samihi=&_sadis=15&_stpos=95120&_sargn=-1%26saslc%3D1&_salic=1&_sop=13&_dmd=1&_ipg=200&LH_Complete=1
Customer demand based data, exemplary as to why the company is not sharing units shipped data publicly.
Yep-as-suspected-may-have-fell-for-the-double-speak
The PR does not state that "Goodwin Proctor" is actually handling the 510k filing, which is what was asking in the posts. See the Tom Cruise analogy ;)
Will ask IR "Paul" to confirm who specifically is handling the 510k submission.
Who-is-handling-the-510k-submission-that-was-the-question
BioElectronics-Files-FDA-Premarket-Notification-for-ActiPatch
http://www.bielcorp.com/bioelectronics-files-actipatch-fda-premarket-notification/
Not seeing anything that mentions who is handling the submission.
Vested-interest-in-company-showing-viable-progress
Even if Pump & Dump company, potential ROI on FDA speculative bounce is worthy. But would prefer company turns into a profitable endeavor.
80k-per-what-period-and-how-many-stores
Need both number of items sold in what period and how many channels is the number of items being sold through.
FDA-may-think-otherwise-especially-considering-historical-precedence
Store-growth-not-as-important-as-items-sold-through-stores
It's understood that BIEL has added many/countless new stores, what we don't know and have a need to know is the number of items being sold through these stores.
Radio-Shack had a large number of stores at one time, but lack of demand for the product and services has resulted in failure.
Not-current-information-we-need-sell-through-data-not-stores-where-product-available-data
We need to know how many items being sold, not how many stores where product is available.
You-sure-the-PR-cites-handling-510k-submission
Honestly do not recall, but have some suspicions there maybe some slide of hand occurring.
Kinda like saying that personally familiar with Tom Cruise. But not disclosing that the statement is based on seeing him in the movie theater.
Problem-is-customers-may-not-be-listening
Given lack-luster sales data available, not looking highly rewarding even if FDA Clearance provided. Excluding speculation bounce in PPS.
Well-done-more-correspondence-with-company-required-less-speculation
You-recall-the-specific-team-or-individual-handling-the-510K-submission
Or do you have the actual 510k submission number?
My understanding is the 510k status/details is not shared or publicly available.
Thus, the individuals handling the submission is unknown, could be wrong.
Suspect-not-following-expected-procedures-and-historical-mis-steps
If BIEL were to allocate additional funding any-where it would be on appropriately skilled FDA process experts.
The fact there were historical mistakes that likely offended the authority of the FDA, BIEL is going to have to be near perfect to expect any timely consideration from FDA authorities.
"No-reason-we-should-not-have-clearance-before-end-of-year"
Kinda double speak that has been interpreted as
"clearance by end of year"
which do not think is what was actually stated.
He stated there is no reason we should not have clearance by end of year, not that we would have clearance by end of year.
There-is-no-competitive-disadvantage-in-sharing-sell-through-numbers
Apple as an example readily shares sell through numbers when they are positive, but tends to keep the numbers closer to the vest when they are negative.
There is not competitive advantage gained by knowing sell through numbers, the secret sauce is the channel relationships, not sharing the number of items sold through the channels.
Ask Gartner about the benefits of sharing sell through numbers.
Agreed-do-not-have-to-share-detailed-marketing-strategies
Stand on shoulder of giants like Amazon and eBay.
If product has efficacy then customers will buy it.
Interest is company being as transparent as is feasible with investor. Sharing generalized sell through data is not going to help competitors but could have huge positive impact on PPS if numbers are showing good month over month growth.
Understanding is product has been submitted for patent, this in itself can be a great differentiation for marketing strategies and competitors can not dispute unless there product also has patent applied for.
Ask-the-company-for-data-on-how-many-products-sold-last-month-into-how-many-stores-channels
That is what many of your profitability posts are missing, data from company stating in simple terms how many products are sold from each of the channels available.
Wal-Mart often shares same store sales figures publicly, similar investor relations paradigm. Yes the data can hurt the PPS when negative, but when positive can have very positive impact on PPS.
Show-me-one-other-poster-that-requests-company-share-relevent-data-with-investors
The company has the means to inform the investors with recent sell through data.
Will agree that the FDA status should be kept confidential until clearance is approved, but sell through data should be publicly available data.
Imagine-the-possiblities-if-BIEL-decided-to-be-the-differentiator
Yes there are thousands of companies that are "BAD"
Trying to suggest BIEL could be different and if they are on a path to greatness then they can stand out and show character representative of greatness.
Share with the "public" & "investors" the latest data that they have available.
Understand-same-here-trying-to-help-with-what-data-is-important
The extrapolations presented are well organized, just suggesting that we investors should not have to speculate on profitability, the company is well informed and can share the data if so inclined.
Again, the new channels is spectacular news, but essentially 3-6 month old news, we now need to know how those additional channels are doing and we should not have to wait for the next Q# financials to get indications of sell through rates.
Bottom line suspect if the product was selling into the recently added channels the company would be sharing numbers indicating as such.
The hope is that the product takes of based on efficacy.
Strong proponent that the product will sell itself if it works.
Best marketing campaign known to man kind is a "Great product"
Brand awareness follows a great product.
Agreed-without-doubt-gotta-have-shelve-space
For this company though suggesting that focusing on excellent online media presence for education purposes is far more cost effective than other media channels and content methodologies.
The same videos showing customer testimonials and product differentiation can be re-used in all online channels once translated and as well can be used aside physical produce shelve space with those little video vignettes available in physical store shelves.
The company needs to be cash wise, the investor should be requesting better allocation of funding being provided.
Well-done-move-onto-asking-tangible-questions
Focus energies on requesting viable "current" data from company.
Less time trying to help sell shares, more time requesting meaningful data from company.
The company has the data, just needs to be shared to allow investors to make informed decisions
Not-attacking-defending-the-little-guy-unsuspecting-investors-need-data
Speculating on new sales channels is at this time "Old 'Pumped' News"
Company needs to share sell through numbers, you should be asking same thing of the company.
Getting less interested in how many channels are available, assume company has enough channels available to characterize if product will sell through the additional channels. We should not have to speculate anymore, we should be able to invest based on sell-through data shared from company.
IE: Whats the customer demand, not whats the availability, product is available, need to know if customers are buying product?
Amazon-vs-Wall-Mart-might-dispuate-this-premise
BIEL should be focused on internet sales channels, not physical store-front shelve space.
Suspecting this "additional channels" is more Pump-&-Dump, otherwise the company would be sharing sell through data.
Ok, fine, Company has many new channels, question is how many items are being sold through the channels, that's what the investor wants to know at this time. Additional channels being added is old news, its now time to show sell through numbers.
Without-sell-through-data-from-company-additional-channels-is-not-credible-data-point
Company-will-provide-unit-sold-data-when-ready
Avoid relying on speculative extrapolated data, the company will release units shipped/sold when ready to share publicly.
As well, see: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=119342198
Real customer demand data, showing poor sales numbers compared to similar product in similar channel.
Facts-Actipatch-6+27-items-sold-vs-Icy-Hot-Tens-274-items-sold
Following a comparative search for:
Icy Hot Smart Relief Tens
Shows 274 listings "Sold"
--> http://www.ebay.com/sch/i.html?_nkw=Icy+Hot+Smart+Relief+Tens+&_in_kw=1&_ex_kw=&_sacat=0&LH_Sold=1&_udlo=&_udhi=&_samilow=&_samihi=&_sadis=15&_stpos=95120&_sargn=-1%26saslc%3D1&_salic=1&_sop=12&_dmd=1&_ipg=200&LH_Complete=1
Then, Actipatch
Shows 6+27 listings "Sold"
--> http://www.ebay.com/sch/i.html?_from=R40&_nkw=Actipatch&_in_kw=1&_ex_kw=&_sacat=0&LH_Sold=1&_udlo=&_udhi=&_samilow=&_samihi=&_sadis=15&_stpos=95120&_sargn=-1%26saslc%3D1&_salic=1&_sop=13&_dmd=1&_ipg=200&LH_Complete=1
Customer demand based data, exemplary as to why the company is not sharing units shipped data publicly.
This-is-called-overly-optimistic-not-data-or-fact-checked-investing